EndoSee Corp., a Los Altos, California company, is seeking to raise $2.5 million to commercialize an investigational device that makes office hysteroscopy possible.
The company has already raised $1.6 million.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Hysteroscopy involves evaluation of the uterine cavity, including the endometrium using endoscopic tools. A hysteroscope can be used to detect endometrial polyps and other gynecological problems.. Generally, hysteroscopy is performed in a hospital and surgical centers, but office hysteroscopy is also possible.
EndoSee’s investigational device allows the procedure to be done at an OB-GYN’s office. EndoSee’s hysteroscope is a handheld device that has a screen about the size of an smartphone which has an integrated camera. Conventional hysteroscopes need external lighting and display the image on a separate computer screen.
According to the regulatory filing, EndoSee’s officers are Dr. Paul Indman, a gynecologist, Shih-Ping(Bob) Wang and Xialong (Bruce) OuYang and Kevin Rooney.
